Canada’s Weston family, known for philanthropy, is now backing innovation. Wittington Investments’ new fund led a $14M financing for Grey Matter Neurosciences, a startup licensing focused ultrasound technology from Sunnybrook Research Institute.This non-invasive technology, pioneered by Dr. Kullervo Hynynen, aims to treat Alzheimer’s by enhancing cognition using a helmet-like device. Grey Matter’s CEO, Jeffrey Coull, plans safety trials with seed funding.
Jim Orlando of Wittington Ventures said the fund seeks to close Canada’s commercialization gap in health tech. The deal is supported by TIAP, Ontario Brain Institute, and others.
Want to know more? Check out the source code on the Globe and Mail.